MYLAN PHARMACEUTICALS INC - NEW AWARD WITH MYLAN PHARMACEUTICALS FOR FLUTICASONE EFFECTIVE 8-1-21 TO 7-31-22 BASE + 4 ONE-YEAR OPTIONS.
Key Details
Description
NEW AWARD WITH MYLAN PHARMACEUTICALS FOR FLUTICASONE EFFECTIVE 8-1-21 TO 7-31-22 BASE + 4 ONE-YEAR OPTIONS.
Context & Analysis
On Jan 15, 2026, Department of Veterans Affairs to MYLAN PHARMACEUTICALS INC for new award with mylan pharmaceuticals for fluticasone effective 8-1-21 to 7-31-22 base + 4 one-year options.. The award is classified under NAICS 325412 — PHARMACEUTICAL PREPARATION MANUFACTURING and issued as a firm fixed price contract. Competition extent: full and open competition with 3 offers received. The procurement used a NO SET ASIDE USED. set-aside. This award is one of several similar procurements from Department of Veterans Affairs under NAICS 325412 — related awards are listed below.
Contractor Information
Similar Awards
EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2026 NOVEMBER
MCKESSON CORPORATION
$1.4B
EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2026 OCTOBER
MCKESSON CORPORATION
$1.2B
EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2026 DECEMBER
MCKESSON CORPORATION
$1.1B
EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2026 JANUARY
MCKESSON CORPORATION
$1.1B
LENALIDOMIDE FOR THE SALISBURY VAMC, CHARLOTTE HCC, AND KERNERSVILLE HCC.
EXELAN PHARMACEUTICALS INC
$5.1M
Stay Updated
Get notified about new opportunities matching your interests.